LATEST BLOG ARTICLES
VIEW ALL →Gates Foundation divests from Microsoft: implications for investors
The Gates Foundation's complete sale of Microsoft shares raises questions for investors. Discover the implications and insights here.
SpaceX's IPO filing ignites renewed interest in US mini-IPOs
SpaceX's IPO announcement triggers a surge in mini-IPO activity across US markets, changing the fundraising landscape.
Boeing triumphs in 737 MAX fraud case amid LOT Polish Airlines' allegations
Boeing prevails in court, dismissing claims from LOT Polish Airlines over the 737 MAX system linked to fatal crashes.
Strategies for investing £250 monthly in FTSE shares to achieve £10,000 passive income
Discover how to invest £250 a month in FTSE shares to generate £10,000 in passive income for life.
Peec AI surges past $10 million in annual revenue amid shift in European tech startups
Peec AI achieves $10 million in annual revenue, illustrating a key trend of growth-focused startups in Europe.
Investing in UK shares: fortunes of the past and lessons learned
Exploring lessons from the past for investing in UK shares and building wealth in today’s market.
Google challenges antitrust ruling over Apple search deal
Google appeals a major monopoly ruling affecting its deal with Apple in search markets, igniting further legal battles.
Canada's emerging prediction market: A new frontier for young investors
Prediction markets are gaining traction in Canada, attracting the attention of young investors looking for alternative trading options.
Consumer anxieties escalate as inflation persists
A recent JD Power report reveals soaring concerns over inflation, causing many Americans to delay significant purchases.
Nvidia's new dividend strategy: Will it rival Apple's success?
As Nvidia raises its dividend, experts weigh its implications for investors seeking income.
AMD plans $10 billion investment in Taiwan to enhance AI chip capabilities
AMD will invest $10 billion in Taiwan to strengthen its AI chip partnerships and technology.
What drove Liminatus Pharma's 79% surge in after-hours trading?
Discover the reasons behind Liminatus Pharma's 79.34% stock surge following a merger announcement with InnocsAI.